Dr. Sharon Rosenzweig-Lipson has dedicated her career to leading drug discovery and medications development for psychiatric and neurologic indications in the pharmaceutical industry, including American Cyanamid, American Home Products, Wyeth and Pfizer. She is currently the Vice-President of Research and Development at AgeneBio with a focus on development of innovative therapeutics to preserve and restore brain function in neurodegeneration patients.